Login to your account
Don’t have an account?
Create a Free Account
x
Filter:
Filters applied
- CJCA - COVID-19
- electrophysiologyRemove electrophysiology filter
- echocardiographyRemove echocardiography filter
- 2018 - 2023Remove 2018 - 2023 filter
- Canadian Journal of CardiologyRemove Canadian Journal of Cardiology filter
Author
- Blankstein, Ron1
- Carr, James1
- Dearani, Joseph A1
- Dilsizian, Vasken1
- Dorbala, Sharmila1
- Gin, Kenneth1
- Harrington, Robert A1
- Krahn, Andrew D1
- Leipsic, Jonathon1
- Légaré, Jean-François1
- Mahmud, Ehtisham1
- Packard, Alan1
- Poppas, Athena1
- Russo, Andrea M1
- Sathananthan, Janarthanan1
- Swaminathan, Madhav1
- Thourani, Vinod H1
- Virani, Alice1
- Virani, Sean1
- Webb, John G1
- Wood, David A1
Keyword
- cardiac computed tomography1
- cardiac magnetic resonance imaging1
- cardiovascular1
- cardiovascular procedures1
- cardiovascular surgery1
- coronavirus disease-20191
- COVID-191
- COVID-19 pandemic1
- CV1
- diagnostic tests1
- HCW1
- health care worker1
- interventional cardiology1
- nuclear cardiac imaging1
- personal protective equipment1
- PPE1
1 Results
- Special Article
Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership
Canadian Journal of CardiologyVol. 36Issue 7p971–976Published online: May 4, 2020- David A. Wood
- Ehtisham Mahmud
- Vinod H. Thourani
- Janarthanan Sathananthan
- Alice Virani
- Athena Poppas
- and others
Cited in Scopus: 14The coronavirus disease-2019 (COVID-19) pandemic has led to marked global morbidity and mortality (1–3). There have been appropriate but significant restrictions on routine medical care to comply with public health guidance on physical distancing and to help preserve or redirect limited resources. Most invasive cardiovascular (CV) procedures and diagnostic tests have been deferred with North American CV societies advocating for intensified triage and management of patients on waiting lists (4). Unfortunately, patients with untreated CV disease are at increased risk of adverse outcomes (5).
